Enhance Skin Products Inc. (EHSK) Financials Nov 1
Post# of 250675
Posted On: 11/17/2014 1:45:50 AM
Enhance Skin Products Inc. (EHSK) Financials Nov 12, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Enhance Skin Products Inc.
Fiscal year is May-April. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1,376 5,399 294 3,089 1,081
Cost of Goods Sold (COGS) incl. D&A 10,386 88,128 0 - -
COGS excluding D&A 243 77,985 0 - -
Depreciation & Amortization Expense 10,143 10,143 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 10,143 10,143 0 0 0
Gross Income (9,010) (82,729) 294 - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 653,418 823,215 800,075 247,837 267,006
Research & Development 0 0 0 0 0
Other SG&A 653,418 823,215 800,075 247,837 267,006
Other Operating Expense 77,090 0 0 0 0
Unusual Expense 0 114,154 3,450 (1.63M) 0
EBIT after Unusual Expense 0 (114,154) (3,450) 1.63M 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 344 - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 - 0 0 0
Gross Interest Expense 0 - 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Minority Interest Expense 0 0 0 0 0
Net Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (739,174) (1.02M) (803,231) 1.39M (265,925)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (739,174) (1.02M) (803,231) 1.39M (265,925)
EPS (Basic) (0.02) (0.02) (0.02) 0.03 ()
Basic Shares Outstanding 49.25M 51.84M 53.25M 54.25M 85.21M
EPS (Diluted) (0.02) (0.02) (0.02) 0.03 ()
Diluted Shares Outstanding 49.25M 51.84M 53.25M 54.25M 85.21M
EBITDA (729,375) (895,801) (799,781) (244,748) (265,925)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Enhance Skin Products Inc.
Fiscal year is May-April. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 1,376 5,399 294 3,089 1,081
Cost of Goods Sold (COGS) incl. D&A 10,386 88,128 0 - -
COGS excluding D&A 243 77,985 0 - -
Depreciation & Amortization Expense 10,143 10,143 0 0 0
Depreciation 0 0 0 0 0
Amortization of Intangibles 10,143 10,143 0 0 0
Gross Income (9,010) (82,729) 294 - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 653,418 823,215 800,075 247,837 267,006
Research & Development 0 0 0 0 0
Other SG&A 653,418 823,215 800,075 247,837 267,006
Other Operating Expense 77,090 0 0 0 0
Unusual Expense 0 114,154 3,450 (1.63M) 0
EBIT after Unusual Expense 0 (114,154) (3,450) 1.63M 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 344 - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 - 0 0 0
Gross Interest Expense 0 - 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Minority Interest Expense 0 0 0 0 0
Net Income (739,174) (1.02M) (803,231) 1.39M (265,925)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (739,174) (1.02M) (803,231) 1.39M (265,925)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (739,174) (1.02M) (803,231) 1.39M (265,925)
EPS (Basic) (0.02) (0.02) (0.02) 0.03 ()
Basic Shares Outstanding 49.25M 51.84M 53.25M 54.25M 85.21M
EPS (Diluted) (0.02) (0.02) (0.02) 0.03 ()
Diluted Shares Outstanding 49.25M 51.84M 53.25M 54.25M 85.21M
EBITDA (729,375) (895,801) (799,781) (244,748) (265,925)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)